Recruiting

Artificial Intelligence

Sponsor:

Orlando Health, Inc.

Code:

NCT06564571

Conditions

Pancreatic Cancer

Pancreas Disease

Pancreatic Cyst

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Patients undergoing endoscopic ultrasound procedures

Study Details

Brief summary:

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Conditions

Pancreatic Cancer

Pancreas Disease

Pancreatic Cyst

Study ID

NCT06564571

Start date

Jan 19, 2024

Status verified date

Aug, 2024

Completion date

Dec, 2027

Anticipated

Primary completion date

Dec, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age ≥ 18 years
  • Any patient undergoing endoscopic ultrasound examination

Exclusion Criteria:

  • Age < 18 years

Study Design

Enrollment

310 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients undergoing endoscopic ultrasound procedures

Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.

Interventions

Patients undergoing endoscopic ultrasound procedures

Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.

Primary outcome measure

  • Rate of detection pancreatic abnormalities by AI [ Time Frame: 1 day ]

Central Contacts and Locations

Central contacts

Shyam Varadarajulu, MD

321-841-2431shyam.varadarajulu@orlandohealth.com

Barbara Broome

321-841-4356barbara.broome@orlandohealth.com

Locations

Orlando Health

Recruiting

Orlando, Florida, United States, 32806

Contacts

Shyam Varadarajulu, MD

321-841-2431shyam.varadarajulu@orlandohealth.com

Barbara Broome

321-841-4356barbara.broome@orlandohealth.com

More Information

Sponsor

Orlando Health, Inc.

Last update posted

May 31, 2025

Last verified

Aug, 2024

Keywords

  • pancreatic disease
  • pancreatic cancer
  • pancreatic cyst
  • artificial intelligence

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Orlando Health, Inc. on 2025-05-31.